Về công ty

Shenzhen Hybio Pharmaceutical Co., Ltd. (翰宇药业) is a high-tech enterprise which is engaged in research, development, production, and sales of polypeptide drugs. On the basis of strict production management and quality control according to the GMP strictly, it breaks through the bottle-neck of the polypeptide drugs' large-scale production technology by means of introduction digestion, independent innovation, and any other patterns. Shenzhen Hybio Pharmaceutical has successively applied for 38 patents, with 5 patents for invention, 7 national new drug certificates, 5 new drug clinical trial permissions, and 45 drug registration letters. The drugs are mainly used to treat diseases such as digestive diseases, cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, tumors, senile diseases, and more.

CN
Không xác định
Không xác định
Chưa xác minh công ty